BCR and neoplasm: The scRNA-seq analysis of Havcr1BKO B cells from tumours and dLNs indicated a remarkable improvement for BCR sensing, activation, and immune co-stimulation gene signatures of B cells, along with increased expression of characteristics associated with IFN response.